Newable Private Investing
VC Fund
London, United Kingdom
Newable Private Investing is a VC fund in London focused on Software and Health Care. Newable Ventures is a private investment group that connects early-stage investors with high-growth scale-up companies. They provide Private Investors, Family Offices, and Corporate Investors the opportunity to invest in potentially high-growth early-stage knowledge-intensive companies. Many of their Investors not only invest in the companies theypresent but also work alongside them as Lead Investors to help them unleash their potential.Having been in operation for over 30 years they have developed an extensive ecosystem of investors, co-investors, and partners who they work with to ensure they have an extensive pipeline of early-stage companies to work with. Investors are able to attend their Investor Events to meet entrepreneurs directly or invest in their Funds for a more passive approach. Typically they invest in UK-based innovative companies who qualify for investment under the Enterprise and/ or Seed Enterprise Investment Schemes.
- Total investments:
- 104
- Last investment:
- Lead investor:
- 23%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Newable Private Investing invests in
Stages Newable Private Investing invests in
Countries Newable Private Investing invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $196k–$3.1M
- Series A
- $1.3M–$5.2M
Investment Focus
Industry
- Software 17 (16%)
- Health Care 15 (14%)
- Biotechnology 13 (13%)
- Artificial Intelligence 12 (12%)
- Medical Device 10 (10%)
Stage
- Seed 36 (35%)
- Funding Round 27 (26%)
- Series A 15 (14%)
- Angel 12 (12%)
- Series B 3 (3%)
Country
- United Kingdom 78 (75%)
- United States 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexander Sleigh
Investment Director
|
Investment Director | Total investments: 3 | Find email | |
Anthony Clark
Director
|
Director | Total investments: 0 | Find email | |
Hitesh Thakrar
Director
|
Director | Total investments: 1 | Find email | |
Charles Breese
Director
|
Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Weldfast
|
Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products. | $12.7M / Debt Financing / Jan 15, 2024 | |
Delta g
|
Delta g is a gravity sensing hardware and technology development company that has developed a cutting-edge underground imaging system that leverages quantum technology. It is a spinout from the University of Birmingham. | $2M / Pre-Seed / Jul 05, 2023 | |
EarSwitch
|
EarSwitch is an advancement in in-ear technology that improves how people interact with their surroundings and works to speed up applications in interactive and medical technology worldwide. | Seed / May 16, 2023 | |
RAB Microfluidics
|
RAB-Microfluidics diagnose early signs of failure in rotating equipment such as gearboxes in wind turbines, generators in shipping vessels, engines in mining industry and prevent equipment failure using our patented microfluidic technology and AI capabilities. RAB-Microfluidics have automated the lubricating oil analysis process usingmicrofluidic technology to provide in real-time the data driven information required to identify deterioration of equipment and incipient failure to revolutionise maintenance practices.We are advancing the evolution of maintenance strategies to secure equipment reliability, increase equipment effectiveness and availability through early diagnosis of machine failure across many industries, such as maritime, renewable wind, aerospace and defence, processing, and manufacturing amongst others.Our mission is to provide intelligent insights on machinery condition through data driven automation and digitisation solutions to achieve our vision of effectively transitioning businesses Condition-based Maintenance (CbM) and Predictive Maintenance (PdM) strategies. | $2.9M / Series B / Aug 30, 2022 | |
|
RAB Microfluidics
|
RAB-Microfluidics diagnose early signs of failure in rotating equipment such as gearboxes in wind turbines, generators in shipping vessels, engines in mining industry and prevent equipment failure using our patented microfluidic technology and AI capabilities. RAB-Microfluidics have automated the lubricating oil analysis process usingmicrofluidic technology to provide in real-time the data driven information required to identify deterioration of equipment and incipient failure to revolutionise maintenance practices.We are advancing the evolution of maintenance strategies to secure equipment reliability, increase equipment effectiveness and availability through early diagnosis of machine failure across many industries, such as maritime, renewable wind, aerospace and defence, processing, and manufacturing amongst others.Our mission is to provide intelligent insights on machinery condition through data driven automation and digitisation solutions to achieve our vision of effectively transitioning businesses Condition-based Maintenance (CbM) and Predictive Maintenance (PdM) strategies. | $2.6M / Seed / Aug 30, 2022 | |
QLM Technology
|
Quantum Light Metrology (QLM) is a Bristol, UK- based startup developing ultra-compact, high-precision quantum optical sensors. | $14.7M / Series A / Aug 01, 2022 | |
Space Forge
|
Space Forge make super materials in space that cannot be made on earth. | $10.2M / Seed / Dec 18, 2021 | |
NuVision
|
NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.5M / Venture - Series Unknown / Jul 16, 2021 | |
|
QLM Technology
|
Quantum Light Metrology (QLM) is a Bristol, UK- based startup developing ultra-compact, high-precision quantum optical sensors. | $4.3M / Seed / Apr 29, 2021 | |
|
NuVision
|
NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.2M / Venture - Series Unknown / Apr 22, 2021 | |
| See all 104 investments → | |||
Co-Investors
London Co-Investment Fund
12 deals together
ACF Investors
11 deals together
Angels in MedCity
8 deals together
Scottish Enterprise
7 deals together
Parkwalk Advisors
6 deals together
Development Bank of Wales
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Newable Private Investing invest in?
Newable Private Investing invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 104 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Newable Private Investing's check size?
Newable Private Investing typically joins rounds of $196k–$3.1M at Seed and $1.3M–$5.2M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Newable Private Investing participates in.
How do I contact Newable Private Investing?
Public channels for Newable Private Investing include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Newable Private Investing?
The team at Newable Private Investing includes Alexander Sleigh (Investment Director), Anthony Clark (Director) and Hitesh Thakrar (Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
